Iopromide Injection Shortage

• • Ultravist injection, Bayer, 240 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0342-10 - discontinued
  • Ultravist injection, Bayer, 300 mg iodine/ mL, 125 mL vial, 1 count, NDC 50419-0344-12 - discontinued
  • Ultravist injection, Bayer, 300 mg iodine/ mL, 150 mL vial, 1 count, NDC 50419-0344-15
  • Ultravist injection, Bayer, 370 mg iodine/ mL, 200 mL vial, 1 count, NDC 50419-0346-20 - discontinued

• • Bayer did not provide a reason for the shortage. Bayer discontinued Ultravist 300 mg in 125 mL vials and 370 mg in 200 mL vials.

• • Ultravist injection, Bayer, 300 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0344-10
  • Ultravist injection, Bayer, 300 mg iodine/ mL, 50 mL vial, 1 count, NDC 50419-0344-05
  • Ultravist injection, Bayer, 370 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0346-10
  • Ultravist injection, Bayer, 370 mg iodine/ mL, 150 mL vial, 1 count, NDC 50419-0346-15
  • Ultravist injection, Bayer, 370 mg iodine/ mL, 50 mL vial, 1 count, NDC 50419-0346-05

Estimated Resupply Dates

• • Bayer has Ultravist 300 mg of iodine/mL in 150 mL vials on back order and the company cannot estimate a release date.